Non-alcoholic Fatty Liver Disease (NAFLD) Clinical Trial
Official title:
How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype?
The hypothesis of this study is that a diet high in sugars will increase abnormalities in blood lipids which are associated with increased cardiovascular disease risk, relative to a diet which is low in sugar. We predict that this potentially adverse effect of dietary sugars on blood lipids will be more pronounced in people with a raised level of stored fat inside their liver, as compared to people with a low level of stored fat.
This study aims to determine the metabolic mechanism(s) by which dietary extrinsic sugars (sucrose and fructose), promote the formation of a high risk dyslipidaemia, known as an atherogenic lipoprotein phenotype (raised plasma triglyceride, low HDL and predominance of small, dense LDL), in men with raised cardio-metabolic risk and percentage of liver fat, as determined by magnetic resonance spectroscopy (MRS). The study examined the impact of diets high and low in extrinsic sugars, on the metabolism of lipids and lipoproteins in vivo, of two groups of men with a high (>10%)and low (<2%)percentage of liver fat, by the trace-labelling of these lipid moieties with stable isotopes, and detection by gas chromatography mass spectrometry. The study had a two-way cross-over design, with two, 12 week dietary interventions separated by a six week wash-out period. The dietary intervention with high and low sugars was achieved by a dietary exchange with supermarket foods, which were consumed within the homes of the participants. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04099147 -
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.
|
||
Completed |
NCT04019561 -
A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.
|
Phase 2 | |
Withdrawn |
NCT00375349 -
Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
|
N/A | |
Active, not recruiting |
NCT04682600 -
The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF
|
N/A | |
Terminated |
NCT02605616 -
Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)
|
Phase 2 | |
Completed |
NCT04165343 -
Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER
|
||
Recruiting |
NCT03151473 -
Longitudinal Observational Study Of Chinese With NAFLD/NASH
|
||
Recruiting |
NCT04820036 -
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
|
N/A | |
Active, not recruiting |
NCT02037321 -
Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic Risk
|
N/A | |
Completed |
NCT01997424 -
Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
|
N/A | |
Completed |
NCT01110577 -
Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)
|
N/A | |
Completed |
NCT00771108 -
Exercise Dose and Nonalcoholic Fatty Liver Disease
|
N/A | |
Recruiting |
NCT04639414 -
Combined Active Treatment in Type 2 Diabetes With NASH
|
Phase 4 | |
Completed |
NCT04450875 -
Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD
|
N/A | |
Recruiting |
NCT02654665 -
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
|
Phase 3 | |
Recruiting |
NCT05699018 -
Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
|
N/A | |
Withdrawn |
NCT02457286 -
Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
|
Phase 1 | |
Withdrawn |
NCT02194894 -
The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
|
N/A | |
Completed |
NCT01811472 -
Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients
|
Phase 2 | |
Completed |
NCT00968747 -
Regulation of FGF21 by Nutritional Challenges
|
N/A |